Menu

Blog

Mar 5, 2019

Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated

Posted by in category: biotech/medical

An antibody against the “don’t eat me” signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.

Author Krista Conger Published on March 5, 2019 March 5, 2019.

Read more

Comments are closed.